INOVIO PHARMACEUTICALS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $3.25M.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $1.08M, a 1.64% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $7.19M, a 977.12% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $1.10M, a 78.91% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2025 was $34.91M, a 3.12% decline from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2024 was $36.03M, a 559.74% increase from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2023 was $5.46M, a 93.42% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, value, new issues for fiscal 2022 was $82.96M, a 60.39% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $3.25M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.08M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $34.91M 10-K · filed 2026-03-12 | |
| 2025-09-30 | $7.19M 10-Q · filed 2025-11-10 | |
| 2025-03-31 | $1.10M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $36.03M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $667.07K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $17.06M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $5.23M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $5.46M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $708.28K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $2.92M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $14.00M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $82.96M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $3.77M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $43.16M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $29.36M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $209.44M 10-K · filed 2024-03-06 | |
| 2021-03-31 | $162.11M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $454.49M 10-K · filed 2023-03-01 | |
| 2020-06-30 | $121.72M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $208.24M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $9.09M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $1.13M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $1.39M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $907.33K 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $29.23M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $12.95M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $1.97M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $94.35M 10-K · filed 2020-03-12 | |
| 2016-12-31 | $6.30M 10-K · filed 2019-03-12 | |
| 2015-12-31 | $81.90M 10-K · filed 2018-03-14 | |
| 2014-12-31 | $59.21M 10-K · filed 2017-03-15 | |
| 2013-12-31 | $18.92M 10-K · filed 2016-03-14 | |
| 2012-12-31 | $5.33M 10-K · filed 2015-03-16 | |
| 2011-12-31 | $1.35M 10-K · filed 2014-03-17 | |
| 2010-12-31 | $2.31M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |